Cystinosis Overview
Learn About Cystinosis
Cystinosis is a condition characterized by accumulation of the amino acid cystine (a building block of proteins) within cells. Excess cystine damages cells and often forms crystals that can build up and cause problems in many organs and tissues. The kidneys and eyes are especially vulnerable to damage; the muscles, thyroid, pancreas, and testes may also be affected.
All three types of cystinosis are caused by mutations in the CTNS gene. Mutations in this gene lead to a deficiency of a transporter protein called cystinosin. Within cells, this protein normally moves cystine out of the lysosomes, which are compartments in the cell that digest and recycle materials. When cystinosin is defective or missing, cystine accumulates and forms crystals in the lysosomes. The buildup of cystine damages cells in the kidneys and eyes and may also affect other organs.
Cystinosis affects approximately 1 in 100,000 to 200,000 newborns worldwide. The incidence is higher in the province of Brittany, France, where the disorder affects 1 in 26,000 individuals.
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Elena Levtchenko practices in Leuven, Belgium. Ms. Levtchenko is rated as an Elite expert by MediFind in the treatment of Cystinosis. Her top areas of expertise are Cystinosis, Fanconi Bickel Syndrome, Fanconi Syndrome, Hypophosphatemia, and Kidney Transplant.
Craig Langman is a Pediatric Nephrologist in Chicago, Illinois. Dr. Langman is rated as an Elite provider by MediFind in the treatment of Cystinosis. His top areas of expertise are Cystinosis, Fanconi Syndrome, Fanconi Bickel Syndrome, Atypical Hemolytic Uremic Syndrome (aHUS), and Kidney Transplant.
Katharina Hohenfellner practices in Hannover, Germany. Ms. Hohenfellner is rated as an Elite expert by MediFind in the treatment of Cystinosis. Her top areas of expertise are Cystinosis, Fanconi Syndrome, Fanconi Bickel Syndrome, Primary Lateral Sclerosis, and Kidney Transplant.
Summary: An open-label, multi-center, phase I/II study to assess the safety, tolerability and efficacy of DFT383 in pediatric participants with nephropathic cystinosis. The purpose of this clinical study is to assess safety, tolerability, and efficacy of DFT383 in participants aged 2 to ≤ 5 years with nephropathic cystinosis. DFT383 is a cellular gene therapy. This study includes an active arm (Cohort 1) o...
Summary: Cystinosis is an inherited disease resulting in poor growth and kidney failure. There is no known cure for cystinosis, although kidney transplantation may help the renal failure and prolong survival. Both the kidney damage and growth failure are thought to be due to the accumulation of the amino acid cystine within the cells of the body. The cystine storage later damages other organs besides the k...
Published Date: May 01, 2013
Published By: National Institutes of Health